Volitionrx (VNRX) Notes Payables (2011 - 2026)

Volitionrx's (VNRX) quarterly Notes Payables came in at $2.4 million in Q4 2025, up 657.26% on a QoQ basis from $319347.0 in Q3 2025.

Volitionrx (VNRX) Notes Payables (2011 - 2026) Analysis & Trends

Volitionrx (VNRX) has 6 years of Notes Payables data on file, last reported at $2.4 million in Q4 2025.

Quarterly Notes Payables changed N/A year-over-year to $2.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.4 million (changed N/A YoY) and the FY2025 annual result came in at $2.4 million, changed N/A from the prior year.
Notes Payables grew to $2.4 million in Q4 2025, from $319347.0 in the prior quarter.
In the past five years, Notes Payables ranged from a high of $2.4 million in Q4 2025 to a low of $166522.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Volitionrx	1.19 Mn	-1.60 Mn	-

Download Data